{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:34:55Z","timestamp":1759332895008,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.imbio.2019.11.007","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T11:26:27Z","timestamp":1574681187000},"page":"151872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma"],"prefix":"10.1016","volume":"225","author":[{"given":"Peter","family":"Hollander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Ginman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Molin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunilla","family":"Enblad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose-Marie","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Glimelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2019.11.007_bib0005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.anndiagpath.2017.11.009","article-title":"Hodgkin lymphoma with an interfollicular growth pattern: a clinicopathologic study of 8 cases","volume":"33","author":"AbdullGaffar","year":"2018","journal-title":"Ann. Diagn. Pathol."},{"issue":"5","key":"10.1016\/j.imbio.2019.11.007_bib0010","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity."},{"issue":"4","key":"10.1016\/j.imbio.2019.11.007_bib0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin\u2019s lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.imbio.2019.11.007_bib0020","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.imbio.2019.11.007_bib0025","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1182\/blood-2017-03-770719","article-title":"Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma","volume":"130","author":"Carey","year":"2017","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.imbio.2019.11.007_bib0030","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1182\/blood-2010-12-323238","article-title":"Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma","volume":"117","author":"Dojcinov","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2019.11.007_bib0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imbio.2019.11.007_bib0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-3-319-67577-0_2","article-title":"Cancer immunotherapy targets based on understanding the t cell-inflamed versus Non-T cell-inflamed tumor microenvironment","volume":"1036","author":"Gajewski","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.imbio.2019.11.007_bib0045","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0609.2011.01652.x","article-title":"Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin\u2019s lymphoma--a population-based study","volume":"87","author":"Glimelius","year":"2011","journal-title":"Eur. J. Haematol."},{"issue":"7","key":"10.1016\/j.imbio.2019.11.007_bib0050","first-page":"B4485","article-title":"On the aetiology of Hodgkin lymphoma","volume":"59","author":"Hjalgrim","year":"2012","journal-title":"Dan. Med. J."},{"issue":"14","key":"10.1016\/j.imbio.2019.11.007_bib0055","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa023141","article-title":"Characteristics of Hodgkin\u2019s lymphoma after infectious mononucleosis","volume":"349","author":"Hjalgrim","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.imbio.2019.11.007_bib0060","doi-asserted-by":"crossref","first-page":"e0204870","DOI":"10.1371\/journal.pone.0204870","article-title":"Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma","volume":"13","author":"Hollander","year":"2018","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.imbio.2019.11.007_bib0065","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1182\/bloodadvances.2017006346","article-title":"High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome","volume":"1","author":"Hollander","year":"2017","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.imbio.2019.11.007_bib0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1006\/smim.1998.0156","article-title":"CD30: expression and function in health and disease","volume":"10","author":"Horie","year":"1998","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.imbio.2019.11.007_bib0075","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/asheducation-2009.1.491","article-title":"Molecular biology of Hodgkin lymphoma","author":"Kuppers","year":"2009","journal-title":"Hematol. \/ Educ. Program Am. Soc. Hematol. Am. Soc. Hematol. Educ. Program"},{"issue":"1","key":"10.1016\/j.imbio.2019.11.007_bib0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrc2542","article-title":"The biology of Hodgkin\u2019s lymphoma","volume":"9","author":"Kuppers","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.imbio.2019.11.007_bib0085","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1172\/JCI61245","article-title":"Hodgkin lymphoma","volume":"122","author":"Kuppers","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.imbio.2019.11.007_bib0090","first-page":"103","article-title":"[Early changes of lymphogranulomatosis]","volume":"69","author":"Lennert","year":"1958","journal-title":"Frankf. Z. Pathol."},{"issue":"7","key":"10.1016\/j.imbio.2019.11.007_bib0095","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1158\/1055-9965.EPI-16-1012","article-title":"Elevated serum levels of sCD30 and IL6 and detectable IL10 precede classical Hodgkin lymphoma diagnosis","volume":"26","author":"Levin","year":"2017","journal-title":"Cancer Epidemiol., Biomarkers & Prevention: Publ. Am. Assoc. Cancer Res., Cosponsored Am. Soc. Preventive Oncol."},{"issue":"11","key":"10.1016\/j.imbio.2019.11.007_bib0100","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/leu.2014.201","article-title":"The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencing","volume":"28","author":"Liu","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.imbio.2019.11.007_bib0105","article-title":"Evaluation of the antibody response to the EBV proteome in EBV-associated classic Hodgkin lymphoma","author":"Liu","year":"2019","journal-title":"Int. J. Cancer Suppl."},{"issue":"1","key":"10.1016\/j.imbio.2019.11.007_bib0110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s40425-018-0479-7","article-title":"High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors","volume":"6","author":"Maleki Vareki","year":"2018","journal-title":"J. Immunother. Cancer"},{"issue":"1\u20133","key":"10.1016\/j.imbio.2019.11.007_bib0115","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12026-013-8464-1","article-title":"CD30: from basic research to cancer therapy","volume":"57","author":"Muta","year":"2013","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.imbio.2019.11.007_bib0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.clim.2014.04.010","article-title":"Programmed death-1 pathway in cancer and autoimmunity","volume":"153","author":"Pedoeem","year":"2014","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.imbio.2019.11.007_bib0125","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/bjh.14317","article-title":"Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC","volume":"175","author":"Plattel","year":"2016","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.imbio.2019.11.007_bib0130","first-page":"379","article-title":"New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin\u2019s disease","volume":"146","author":"Reynolds","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.imbio.2019.11.007_bib0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.semcancer.2014.04.004","article-title":"Co-infections, inflammation and oncogenesis: future directions for EBV research","volume":"26","author":"Rickinson","year":"2014","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.imbio.2019.11.007_bib0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0167-8140(97)00208-9","article-title":"Contiguous pattern spreading in patients with Hodgkin\u2019s disease","volume":"47","author":"Roth","year":"1998","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.imbio.2019.11.007_bib0145","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.immuni.2018.06.012","article-title":"PD-1 controls follicular t helper cell positioning and function","volume":"49","author":"Shi","year":"2018","journal-title":"Immunity"},{"issue":"14","key":"10.1016\/j.imbio.2019.11.007_bib0150","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1200\/JCO.2010.32.8401","article-title":"Molecular pathogenesis of Hodgkin\u2019s lymphoma: increasing evidence of the importance of the microenvironment","volume":"29","author":"Steidl","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.imbio.2019.11.007_bib0155","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.848","article-title":"The expression of the Hodgkin\u2019s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells","volume":"66","author":"Stein","year":"1985","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.imbio.2019.11.007_bib0160","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/1097-0142(197006)25:6<1314::AID-CNCR2820250609>3.0.CO;2-V","article-title":"Significance of focal involvement of lymph nodes for the diagnosis and staging of Hodgkin\u2019s disease","volume":"25","author":"Strum","year":"1970","journal-title":"Cancer"},{"year":"2016","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","key":"10.1016\/j.imbio.2019.11.007_bib0165"},{"issue":"9","key":"10.1016\/j.imbio.2019.11.007_bib0170","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.leukres.2008.02.016","article-title":"TARC and IL-5 expression correlates with tissue eosinophilia in peripheral T-cell lymphomas","volume":"32","author":"Thielen","year":"2008","journal-title":"Leuk. Res."},{"issue":"5","key":"10.1016\/j.imbio.2019.11.007_bib0175","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/ACI.0000000000000198","article-title":"Biomarkers for atopic dermatitis: a systematic review and meta-analysis","volume":"15","author":"Thijs","year":"2015","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2019.11.007_bib0180","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1189\/jlb.3MR0315-136R","article-title":"The role of T cells in the microenvironment of Hodgkin lymphoma","volume":"99","author":"Wein","year":"2016","journal-title":"J. Leukoc. Biol."},{"issue":"7","key":"10.1016\/j.imbio.2019.11.007_bib0185","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1172\/JCI95993","article-title":"Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells","volume":"128","author":"Weniger","year":"2018","journal-title":"J. Clin. Invest."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298519302487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298519302487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:48:52Z","timestamp":1759250932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298519302487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0171298519302487"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2019.11.007","relation":{},"ISSN":["0171-2985"],"issn-type":[{"type":"print","value":"0171-2985"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2019.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"151872"}}